Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
The Oncologist
|
October 9, 2022
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab
Charlotte Manogue Hawkins, Pedro C Barata, Patrick Cotogno, et al.
The American Journal of Emergency Medicine
|
June 9, 2021
Community-based study of cannabis hyperemesis syndrome
Brian Lewis, Erin Leach, Larissa B Fomum Mugri, et al.
Nature Communications
|
August 23, 2014
MicroRNA-378 controls classical brown fat expansion to counteract obesity
Dongning Pan, Chunxiao Mao, Brian Quattrochi, et al.
Annals of Vascular Surgery
|
August 18, 2016
Disseminated Mycotic Aneurysms following Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer: Case Discussion and Systematic Treatment Algorithm
Cheong J Lee, Daniel Davila, Anahita Dua, et al.
Annals of Vascular Surgery
|
February 27, 2016
Preventable Complications Driving Rising Costs in Management of Patients with Critical Limb Ischemia
Anahita Dua, Sapan S Desai, Bhavin Patel, et al.
Molecular Cell
|
April 6, 2005
PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator
Rushad Pavri, Brian Lewis, Tae-Kyung Kim, et al.
Practical Radiation Oncology
|
June 18, 2022
Embracing the Practical Aspects of Theranostics With Prostate-Specific Membrane Antigen-Targeted Lutetium-177
Charlotte E Manogue, Wenzhou Chen, Anthony Mazza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 28, 2023
Prediction of Resistance to <sup>177</sup>Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
Oliver Sartor, Elisa Ledet, Minqi Huang, et al.
Cancer Treatment and Research Communications
|
July 24, 2020
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer
Marcus Moses, Alex Niu, Michael B Lilly, et al.
Environmental Health Perspectives
|
July 11, 2009
A review of events that expose children to elemental mercury in the United States
Robin Lee, Dan Middleton, Kathleen Caldwell, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
The Oncologist
|
October 9, 2022
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab
Charlotte Manogue Hawkins, Pedro C Barata, Patrick Cotogno, et al.
The American Journal of Emergency Medicine
|
June 9, 2021
Community-based study of cannabis hyperemesis syndrome
Brian Lewis, Erin Leach, Larissa B Fomum Mugri, et al.
Nature Communications
|
August 23, 2014
MicroRNA-378 controls classical brown fat expansion to counteract obesity
Dongning Pan, Chunxiao Mao, Brian Quattrochi, et al.
Annals of Vascular Surgery
|
August 18, 2016
Disseminated Mycotic Aneurysms following Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer: Case Discussion and Systematic Treatment Algorithm
Cheong J Lee, Daniel Davila, Anahita Dua, et al.
Annals of Vascular Surgery
|
February 27, 2016
Preventable Complications Driving Rising Costs in Management of Patients with Critical Limb Ischemia
Anahita Dua, Sapan S Desai, Bhavin Patel, et al.
Molecular Cell
|
April 6, 2005
PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator
Rushad Pavri, Brian Lewis, Tae-Kyung Kim, et al.
Practical Radiation Oncology
|
June 18, 2022
Embracing the Practical Aspects of Theranostics With Prostate-Specific Membrane Antigen-Targeted Lutetium-177
Charlotte E Manogue, Wenzhou Chen, Anthony Mazza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 28, 2023
Prediction of Resistance to <sup>177</sup>Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
Oliver Sartor, Elisa Ledet, Minqi Huang, et al.
Cancer Treatment and Research Communications
|
July 24, 2020
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer
Marcus Moses, Alex Niu, Michael B Lilly, et al.
Environmental Health Perspectives
|
July 11, 2009
A review of events that expose children to elemental mercury in the United States
Robin Lee, Dan Middleton, Kathleen Caldwell, et al.
Page
of 9